ASPIRA PATHLAB & DIAGNOSTICS | APOLLO HOSPITALS | ASPIRA PATHLAB & DIAGNOSTICS / APOLLO HOSPITALS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -13.6 | 104.4 | - | View Chart |
P/BV | x | 2.6 | 13.8 | 18.7% | View Chart |
Dividend Yield | % | 0.0 | 0.3 | - |
ASPIRA PATHLAB & DIAGNOSTICS APOLLO HOSPITALS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ASPIRA PATHLAB & DIAGNOSTICS Mar-23 |
APOLLO HOSPITALS Mar-23 |
ASPIRA PATHLAB & DIAGNOSTICS / APOLLO HOSPITALS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 75 | 4,901 | 1.5% | |
Low | Rs | 26 | 3,366 | 0.8% | |
Sales per share (Unadj.) | Rs | 14.0 | 1,155.4 | 1.2% | |
Earnings per share (Unadj.) | Rs | -0.1 | 61.7 | -0.1% | |
Cash flow per share (Unadj.) | Rs | 1.5 | 104.5 | 1.4% | |
Dividends per share (Unadj.) | Rs | 0 | 15.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0.4 | 0.0% | |
Book value per share (Unadj.) | Rs | 12.4 | 425.1 | 2.9% | |
Shares outstanding (eoy) | m | 10.29 | 143.78 | 7.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.6 | 3.6 | 100.2% | |
Avg P/E ratio | x | -583.7 | 67.0 | -871.6% | |
P/CF ratio (eoy) | x | 34.6 | 39.5 | 87.5% | |
Price / Book Value ratio | x | 4.1 | 9.7 | 41.8% | |
Dividend payout | % | 0 | 24.3 | -0.0% | |
Avg Mkt Cap | Rs m | 518 | 594,327 | 0.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 56 | 21,438 | 0.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 145 | 166,125 | 0.1% | |
Other income | Rs m | 3 | 903 | 0.4% | |
Total revenues | Rs m | 148 | 167,028 | 0.1% | |
Gross profit | Rs m | 16 | 20,496 | 0.1% | |
Depreciation | Rs m | 16 | 6,154 | 0.3% | |
Interest | Rs m | 4 | 3,808 | 0.1% | |
Profit before tax | Rs m | -1 | 11,437 | -0.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 2,562 | 0.0% | |
Profit after tax | Rs m | -1 | 8,875 | -0.0% | |
Gross profit margin | % | 11.0 | 12.3 | 89.3% | |
Effective tax rate | % | 0 | 22.4 | -0.0% | |
Net profit margin | % | -0.6 | 5.3 | -11.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 59 | 43,370 | 0.1% | |
Current liabilities | Rs m | 16 | 33,249 | 0.0% | |
Net working cap to sales | % | 29.5 | 6.1 | 485.0% | |
Current ratio | x | 3.7 | 1.3 | 283.2% | |
Inventory Days | Days | 88 | 64 | 137.4% | |
Debtors Days | Days | 590 | 49 | 1,202.7% | |
Net fixed assets | Rs m | 115 | 117,447 | 0.1% | |
Share capital | Rs m | 103 | 719 | 14.3% | |
"Free" reserves | Rs m | 25 | 60,406 | 0.0% | |
Net worth | Rs m | 128 | 61,125 | 0.2% | |
Long term debt | Rs m | 10 | 19,376 | 0.0% | |
Total assets | Rs m | 173 | 160,817 | 0.1% | |
Interest coverage | x | 0.8 | 4.0 | 19.7% | |
Debt to equity ratio | x | 0.1 | 0.3 | 23.8% | |
Sales to assets ratio | x | 0.8 | 1.0 | 80.7% | |
Return on assets | % | 1.9 | 7.9 | 24.0% | |
Return on equity | % | -0.7 | 14.5 | -4.8% | |
Return on capital | % | 2.4 | 18.9 | 12.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0.1 | 0.0% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | 118 | 0.0% | |
Fx inflow | Rs m | 0 | 587 | 0.0% | |
Fx outflow | Rs m | 0 | 692 | 0.0% | |
Net fx | Rs m | 0 | -105 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 13,767 | -0.0% | |
From Investments | Rs m | 2 | -8,706 | -0.0% | |
From Financial Activity | Rs m | -9 | -6,330 | 0.1% | |
Net Cashflow | Rs m | -8 | -1,131 | 0.7% |
Indian Promoters | % | 18.7 | 29.3 | 63.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 65.4 | - | |
FIIs | % | 0.0 | 45.6 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 81.3 | 70.7 | 115.0% | |
Shareholders | 1,512 | 130,664 | 1.2% | ||
Pledged promoter(s) holding | % | 0.0 | 16.1 | - |
Compare ASPIRA PATHLAB & DIAGNOSTICS With: DR. LAL PATHLABS METROPOLIS HEALTHCARE NARAYANA HRUDAYALAYA KIMS VIJAYA DIAGNOSTIC
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ASPIRA PATHLAB & DIAGNOSTICS | APOLLO HOSPITALS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.27% | -6.10% | -0.20% |
1-Month | -2.29% | -8.94% | -0.29% |
1-Year | -3.03% | 31.11% | 53.47% |
3-Year CAGR | 2.29% | 21.97% | 14.84% |
5-Year CAGR | -1.66% | 37.04% | 19.74% |
* Compound Annual Growth Rate
Here are more details on the ASPIRA PATHLAB & DIAGNOSTICS share price and the APOLLO HOSPITALS share price.
Moving on to shareholding structures...
The promoters of ASPIRA PATHLAB & DIAGNOSTICS hold a 18.7% stake in the company. In case of APOLLO HOSPITALS the stake stands at 29.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASPIRA PATHLAB & DIAGNOSTICS and the shareholding pattern of APOLLO HOSPITALS.
Finally, a word on dividends...
In the most recent financial year, ASPIRA PATHLAB & DIAGNOSTICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
APOLLO HOSPITALS paid Rs 15.0, and its dividend payout ratio stood at 24.3%.
You may visit here to review the dividend history of ASPIRA PATHLAB & DIAGNOSTICS , and the dividend history of APOLLO HOSPITALS.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.